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The methods of screening tests are stool examinations, such as 
the fecal occult blood test (FOBT) and the fecal DNA test, and 
evaluations of images, such as flexible sigmoidoscopy, colonos-
copy, double-contrast barium enema and computed tomographic 
colonography. The advantages and the disadvantages of differ-
ent screening tests have been the subject of intense debate. An 
accurate screening test would have high sensitivity when an 
adenomatous polyp or cancer is present and high specificity in 
their absence. Randomized controlled trials using the FOBT as 
the screening strategy have shown a reduction in mortality due 
to colorectal cancer. The fecal DNA panel (k-ras, APC, p53 and 
BAT-26) was more sensitive than the FOBT for invasive cancer 
and adenomas, but its cost effectiveness is controversial [1]. 
Colonoscopy has theoretical advantages over other screening 
tests, including direct visualization of the entire colon and, more 
importantly, removal of precancerous adenomatous lesions. 
Colonoscopy has averted the greatest number of deaths from 
colorectal cancer (31%), followed by annual fecal occult blood 
testing (29%), flexible sigmoidoscopy (21%) and biennial fecal 
occult blood testing (19%) [2, 3]. The FOBT was preferred as a 
screening test by 70.2% of the participants and colonoscopy by 
9.3% because colonoscopy was significantly more time con-
suming, was disturbing, painful, and annoying, and involved 
risks [4]. In conclusion, screening based on stool tests with 
colonoscopic follow-up of positive test results might offer a 
high potential for early detection or prevention of colorectal 
cancer.
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